-transparent.png){kind=logo}
Antiviral effects of acyclovir (ACV) and antibody were studied in athymic nude mice inoculated intracutaneously in the midflank with herpes simplex virus type 1. Three hours after virus inoculation, treatment was initiated. In ACV-treated mice, the development of skin lesions was inhibited and the mean survival time was prolonged as compared with controls. Treatment with ACV markedly reduced the viral titers both at the inoculation site and in the neural tissues (dorsal root ganglia, spinal cord and brain). Transfer of antibody was also effective in controlling infection as described previously. The use of ACV plus antibody was more effective than the use of ACV alone and in 5 of 17 mice the disease was completely inhibited. Furthermore, in the mice that survived, latent infections in the ganglia were also prevented. These results indicate that treatment with ACV plus antibody is highly effective against herpes simplex virus infection in the immunocompromised host.
M Yamamoto, and
Y Hayashi, and
L L Tang, and
R Mori
October 1986,
The Journal of antimicrobial chemotherapy,
M Yamamoto, and
Y Hayashi, and
L L Tang, and
R Mori
March 1989,
Antimicrobial agents and chemotherapy,
M Yamamoto, and
Y Hayashi, and
L L Tang, and
R Mori
January 1982,
Microbiology and immunology,
M Yamamoto, and
Y Hayashi, and
L L Tang, and
R Mori
May 1987,
Antiviral research,
M Yamamoto, and
Y Hayashi, and
L L Tang, and
R Mori
April 1984,
Antiviral research,
M Yamamoto, and
Y Hayashi, and
L L Tang, and
R Mori
June 1974,
The Kitasato archives of experimental medicine,
M Yamamoto, and
Y Hayashi, and
L L Tang, and
R Mori
July 1982,
The American journal of medicine,
M Yamamoto, and
Y Hayashi, and
L L Tang, and
R Mori
July 1988,
Zhongguo yao li xue bao = Acta pharmacologica Sinica,
M Yamamoto, and
Y Hayashi, and
L L Tang, and
R Mori
January 1996,
The Journal of infectious diseases,
M Yamamoto, and
Y Hayashi, and
L L Tang, and
R Mori
September 1982,
The New England journal of medicine,
